Our studies on cell cycle arrest and death in glucose-fasted HCC cells also point out the key role of AMPK in the HCC scenario, and suggest that glucose starvation alone or together with pharmacological AMPK activators can be targeted to impair tumor growth. Here, PRKAA1 is linked to hepatocellular carcinoma.